Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease colorectal cancer
Phenotype C0009324|ulcerative colitis
Sentences 45
PubMedID- 25649787 A retrospective dutch nationwide population-based analysis found that approximately 20% of colorectal cancer cases in patients with ulcerative colitis presented prior to the recommended initiation of screening colonoscopy [8].
PubMedID- 23435402 Five-year mortality in colorectal cancer patients with ulcerative colitis or crohn's disease: a nationwide population-based cohort study.
PubMedID- 25823771 It has been more than 40 years since the colonoscopic surveillance program for colorectal cancer (crc) in patients with long-standing ulcerative colitis (uc) was introduced (1).
PubMedID- 23139655 Surgical procedure for sporadic colorectal cancer in patients with mild ulcerative colitis.
PubMedID- 21873166 Clinical course of colorectal cancer in patients with ulcerative colitis.
PubMedID- 23867875 Methylated eyes absent 4 (eya4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.
PubMedID- 24295648 Unique endoscopic findings of colitis-associated colorectal cancer in a patient with ulcerative colitis and lynch syndrome.
PubMedID- 24766737 In a meta­analysis based on 116 studies, the overall prevalence of colorectal cancer in patients with ulcerative colitis was 3.7%.
PubMedID- 23459532 [surgical treatment of colorectal cancer associated with ulcerative colitis].
PubMedID- 22610004 Challenges in calculating the risk for colorectal cancer in patients with ulcerative colitis.
PubMedID- 23446340 The risk of colorectal cancer in patients with long-standing ulcerative colitis or colonic crohn's disease is increased.
PubMedID- 24496155 Although only 1% of all cases of colorectal cancer (crc) occur in patients with ulcerative colitis (uc) or crohn's disease (cd), patients with ibd represent one of the highest risk groups for developing this dreaded complication.
PubMedID- 22289873 Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.
PubMedID- 20656250 The incidence of colorectal cancer associated with ulcerative colitis (uc) increases with time.
PubMedID- 21793125 Background: ulcerative colitis (uc) is associated with colorectal cancer.
PubMedID- 22156448 Does colorectal cancer in ulcerative colitis patients constitute a risk for chemotherapy refractoriness.
PubMedID- 25834332 colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer.
PubMedID- 23118901 Inflammation plays a crucial role in the cancer development [4], and chronic inflammation leading to inflammatory bowel disease (crohn's disease and ulcerative colitis) is associated with colorectal cancer risk [5].
PubMedID- 23295694 An average of 1.6% of patients with ulcerative colitis was diagnosed with colorectal cancer during 14 years of follow-up in population-based cohorts.
PubMedID- 21466491 How to manage the risk of colorectal cancer in ulcerative colitis.
PubMedID- 22312529 [17] reported good clinical results with laparoscopic isr combined with transanal manipulation prior to the abdominal phase for two patients with t2 very low rectal cancer and total colectomy for two patients with ulcerative colitis complicated by t1 colorectal cancer; feasibility for t3 low rectal cancer could not be evaluated due to the small number of patients.
PubMedID- 21040676 [development of colorectal cancer in ulcerative colitis].
PubMedID- 23189226 Despite the fact that colorectal cancer complicating ulcerative colitis only accounts for approximately 2% of all cases of colorectal cancer in the general population, it is considered a serious complication and accounts for approximately 15% of all deaths associated with inflammatory bowel diseases.
PubMedID- 25605985 Copy number variations are progressively associated with the pathogenesis of colorectal cancer in ulcerative colitis.
PubMedID- 25888857 Avoiding restorative proctocolectomy for colorectal cancer in patients with ulcerative colitis based on preoperative diagnosis involving p53 immunostaining: report of a case.
PubMedID- 24733679 Risk of colorectal cancer in ulcerative colitis.
PubMedID- 25797989 Surveillance colonoscopy (sc) is considered important for the early detection and treatment of colorectal cancer (crc) in patients with ulcerative colitis (uc).
PubMedID- 20157368 In patients with inflammatory bowel disease such as ulcerative colitis, the risk of colorectal cancer begins to increase after 8 to 10 years and increases approximately 1% per year thereafter, particularly in patients with pancolitis [15].
PubMedID- 24262637 Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis.
PubMedID- 25280558 The risk of colorectal cancer in patients with ulcerative colitis.
PubMedID- 23207933 The role of chemoprevention of colorectal cancer with 5-aminosalicylates in ulcerative colitis.
PubMedID- 21404516 colorectal cancer, in patients with ulcerative colitis, is detected in the resected tissue of approximately 5% of patients, according to the literature.
PubMedID- 22552273 Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
PubMedID- 21425209 Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and runx3 methylation.
PubMedID- 21618350 Background: chronic ulcerative colitis (uc) is associated with an increased colorectal cancer risk which may be secondary to repetitive mucosal injury.
PubMedID- 26357617 Risk factors for developing cca in psc patients include elevated serum bilirubin, chronic ulcerative colitis with colorectal cancer or dysplasia, variceal bleeding, proctocolectomy, and polymorphisms of the natural killer group 2, member d (nkg2d) gene (encoding a protein involved in nk cell activity).78, 82, 83 the duration of psc may not be a risk factor for the development of cca, which is contrary to the risk factors of neoplasia in inflammatory bowel disease.77 it is suggested that dominant strictures, defined as a common bile duct stenosis with less than 1.5 mm diameter remaining in the common bile duct or a common hepatic duct stenosis close to the bifurcation leaving less than 1.0 mm diameter of the common hepatic duct,84, 85 may serve as primary indicators of concomitant cca.86 it is very challenging to distinguish between benign strictures from psc activity and cca as they can have similar characteristics on imaging.
PubMedID- 25981516 Psc is a premalignant condition, associated with higher rates of hepatobiliary and colorectal cancer in patients with ulcerative colitis (uc).
PubMedID- 22292619 The risk of colorectal cancer in ulcerative colitis patients is estimated to be as high as 40%.
PubMedID- 25003294 Dysplasia in ulcerative colitis as a predictor of unsuspected synchronous colorectal cancer.
PubMedID- 20698214 Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in japan.
PubMedID- 19906011 The development of colorectal cancer in ulcerative colitis is a function of disease duration, with the risk approaching 14% at 25 years.
PubMedID- 25347248 [colorectal cancer in ulcerative colitis.]
PubMedID- 21089179 The risk of colorectal cancer is increased in patients with long-standing ulcerative colitis.
PubMedID- PMC4070603 The risk of colorectal cancer in ulcerative colitis: a meta-analysis.
PubMedID- 21647200 Although progress has been made in the understanding of inflammation-driven carcinogenesis, markers based on these findings possess insufficient sensitivity or specificity to be usable as reliable biomarkers for risk of colorectal cancer development in patients with ulcerative colitis.

Page: 1